Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples